Published in World J Gastroenterol on January 28, 2010
Association of PTPN22 gene polymorphism and systemic lupus erythematosus in a cohort of Egyptian patients: impact on clinical and laboratory results. Rheumatol Int (2011) 0.78
rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls. Ann Gastroenterol (2017) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet (2004) 13.71
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet (2004) 12.25
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl (1989) 9.56
The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol (2003) 8.28
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet (2005) 6.48
Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet (2005) 5.00
Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes (2004) 4.81
Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet (2004) 4.46
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med (1999) 3.48
Protein tyrosine phosphatases and the immune response. Nat Rev Immunol (2005) 2.88
Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol (2006) 2.79
Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet (2001) 2.64
PTPN22: setting thresholds for autoimmunity. Semin Immunol (2006) 2.54
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab (2004) 2.44
Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood (1999) 2.40
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J (1996) 2.37
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet (2005) 1.86
Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum (2005) 1.79
The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol (2000) 1.72
Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol (1991) 1.71
Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol (1999) 1.67
Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet (2004) 1.44
Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun (2005) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol (2006) 1.28
Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther (2001) 1.25
Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord (2004) 1.00
Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin Nutr (2005) 0.98
The common genetic hypothesis of autoimmune/inflammatory disease. Curr Opin Allergy Clin Immunol (2001) 0.98
A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens (2005) 0.92
PTPN22 gene polymorphism in Behçet's disease. Tissue Antigens (2007) 0.88
The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens (2005) 0.84
A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet (2005) 0.84
Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol (2002) 1.74
Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients. Ann Clin Microbiol Antimicrob (2010) 1.17
[Association Budd Chiari syndrome, antiphospholipid syndrome and Grave's disease]. Tunis Med (2009) 0.94
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob (2010) 0.90
Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review. Tunis Med (2007) 0.88
Efficacy of diosmectite (smecta) in the treatment of acute watery diarrhoea in adults: a multicentre, randomized, double-blind, placebo-controlled, parallel group study. Gastroenterol Res Pract (2011) 0.86
Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Fam Cancer (2008) 0.86
Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2009) 0.85
Variceal band ligation in the prevention of variceal bleeding: a multicenter trial. Saudi J Gastroenterol (2011) 0.84
Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis. Biomark Res (2013) 0.84
Median arcuate ligament syndrome: a rare cause of recurrent abdominal pain. Tunis Med (2013) 0.84
Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine (2008) 0.84
Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease. Digestion (2011) 0.83
Is serum transthyretin a reliable marker of nutritional status in patients with end-stage renal disease? Clin Biochem (2008) 0.83
Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection. J Infect (2006) 0.83
[Survival in cirrhosis]. Tunis Med (2010) 0.82
Transverse myelitis associated with chronic viral hepatitis C. Tunis Med (2010) 0.82
Cerebral thrombosis in inflammatory bowel disease: a report of four cases. J Crohns Colitis (2011) 0.82
Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J Gastroenterol (2009) 0.82
Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol (2007) 0.81
Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease. J Neuroimmunol (2006) 0.81
The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians. Ann Saudi Med (2004) 0.81
Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol (2013) 0.81
Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary Pancreat Dis Int (2011) 0.80
[Epidemiology of hepatitis C in Tunisia]. Tunis Med (2013) 0.80
Evaluation of nutritional status in patients with liver cirrhosis. Tunis Med (2010) 0.80
T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm (2002) 0.80
Another case of serrated adenoma of the stomach. J Clin Pathol (2007) 0.80
[IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients]. Tunis Med (2010) 0.79
Visceral leishmaniasis after kidney transplantation: report of a new case and a review of the literature. Transplant Rev (Orlando) (2013) 0.79
Acute rejection episodes after kidney transplantation. Saudi J Kidney Dis Transpl (2009) 0.79
Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant (2011) 0.79
Colonoscopy in elderly: feasibility, tolerance and indications: about 901 cases. Tunis Med (2011) 0.79
Malignant epithelioid hemangioendothelioma: a case report. Oman Med J (2013) 0.78
[Usefulness of endoscopic ultrasonography for diagnosis between multivesicular hydatic cyst and serous cystadenoma of the pancreas. Case report]. Tunis Med (2005) 0.78
Systemic lupus erythematosus and celiac disease. Joint Bone Spine (2011) 0.78
[Celiac disease and idiopathic dilated cardiomyopathy: a fortuitous association?]. Presse Med (2010) 0.78
Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C. Tunis Med (2010) 0.78
Role of genetic polymorphisms in factor H and MBL genes in Tunisian patients with immunoglobulin A nephropathy. Int J Nephrol Renovasc Dis (2010) 0.78
[Hepatitis C in kidney transplantation: comparative study between two Maghrebin centers: Casablanca and Tunis]. Tunis Med (2010) 0.78
VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. J Neuroimmunol (2009) 0.78
[Celiac disease associated to Wilson disease]. Tunis Med (2008) 0.77
[Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients]. Tunis Med (2012) 0.77
[Thrombosis in inflammatory bowel disease: mechanisms and risk factors]. Tunis Med (2009) 0.77
Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis (2011) 0.77
Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients. Clin Chem Lab Med (2003) 0.77
Evaluation of urolithiasis in Crohn's disease in Tunisian patients. Tunis Med (2013) 0.77
Investigation of DNA sequence in the Basal core promoter, precore, and core regions of hepatitis B virus from Tunisia shows a shift in genotype prevalence. Hepat Mon (2012) 0.77
[Prevalence and risk factors of thromboembolic complications in inflammatory bowel disease]. Tunis Med (2011) 0.77
Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol (2009) 0.77
[Auto-immune serological disorders in chronic viral C hepatitis: prevalence and clinical significance]. Tunis Med (2008) 0.77
Endoscopic ultrasonography versus helical CT in diagnosis and staging of pancreatic cancer. Tunis Med (2008) 0.77
CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection. Iran J Kidney Dis (2011) 0.77